Omicron thwarts some of the world’s most-used COVID vaccines

Elie Dolgin

Nature, 2022, vol. 601, issue 7893, 311-311

Abstract: Inactivated-virus vaccines elicit few, if any, infection-blocking antibodies — but might still protect against severe disease.

Keywords: SARS-CoV-2; Vaccines; Public health; Immunology; Virology; Medical research (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
https://www.nature.com/articles/d41586-022-00079-6 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:601:y:2022:i:7893:d:10.1038_d41586-022-00079-6

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-022-00079-6

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().